Perspectives on posttraumatic fibromyalgia: A random survey of Canadian general practitioners, orthopedists, physiatrists, and rheumatologists

Journal of Rheumatology

Volumn 27, Issue 3, 2000, Pages 790-796

  White, Kevin P ^a,b   Østbye, Truls ^a   Harth, Manfred ^a   Nielson, Warren ^a   Speechley, Mark ^a   Teasell, Robert ^a   Bourne, Robert ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Canada; Chronic pain; Fibromyalgia; Fibrositis; Posttraumatic pain; Survey

Indexed keywords

ARTICLE; CANADA; CHRONIC PAIN; CLINICAL FEATURE; FIBROMYALGIA; HUMAN; PREVALENCE; PRIORITY JOURNAL; WHIPLASH INJURY;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CANADA; DATA COLLECTION; FAMILY PRACTICE; FEMALE; FIBROMYALGIA; HUMANS; MULTIVARIATE ANALYSIS; ORTHOPEDICS; PHYSICAL MEDICINE; RANDOM ALLOCATION; RHEUMATOLOGY; WHIPLASH INJURIES;

EID: 0034114357     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Bennett RM. Emerging concepts in the neurobiology of chronic pain: Evidence for abnormal central processing in fibromyalgia. Mayo Clin Proc 1999;74:385-98.
3. White KP, Harth M, Teasell RW. Work disability evaluation and the fibromyalgia syndrome. Semin Arthritis Rheum 1995; 24:371-81.
4. Greenfield S, Fitzcharles M, Esdaile JM. Reactive fibromyalgia syndrome. Arthritis Rheum 1992;35:678-81.
5. White KP, Speechley M, Harth M, Østbye T. The London Fibromyalgia Epidemiology Study: Comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia syndrome (FMS) versus controls. J Rheumatol 1999;26:1577-85.
6. Bennett RM. Disabling fibromyalgia: Appearance versus reality. J Rheumatol 1993;20:8121-4.
7. Romano T. Valid complaints or malingering? Clinical experiences with post-traumatic fibromyalgia syndrome. West Virg Med J 1990;86:198.
8. Waylonis GW, Perkins RH. Post-traumatic fibromyalgia. A long-term follow-up. Am J Phys Med Rehabil 1994;73:403-12.
9. Bohr TW. Fibromyalgia syndrome and myofascial pain syndrome: Do they exist? Neurologic Clin 1995;13:365-84.
10. Rush PJ, Ameis A. Trauma and fibromyalgia: Does the punishment fit the crime? [letter]. J Rheumatol 1995;22:372.
11. Wolfe F. The fibromyalgia syndrome: A consensus report on fibromyalgia and disability. J Rheumatol 1996;23:534-9.
12. Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F. Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997;303:216-9.
13. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
14. White KP, Speechley M, Harth M, Østbye T. The London Fibromyalgia Epidemiology Study (LFES): The prevalence of fibromyalgia syndrome (FMS) in London, Ontario. J Rheumatol 1999;26:1570-6.
15. Kennedy M, Felson DT. A prospective long-term study of fibromyalgia syndrome. Arthritis Rheum 1996;39:682-5.
16. White K, Speechley M, Harth M, Østbye T. Remission Rate in Fibromyalgia Syndrome. (Presented in poster format at the XII Panamerican Congress of Rheumatology, June 21-25, 1998, Montreal, Quebec).
17. Wolfe F, Anderson J, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997;40:1560-70.
18. White KP, Speechley M, Harth M, Østbye T. The London Fibromyalgia Epidemiology Study: Direct health care costs of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999;26:885-9.
19. White KP, Speechley M, Harth M, Østbye T. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario. Arthritis Rheum 1999;42:76-82.
20. Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: New features for diagnosis. Pain 1988;32:21-6.
21. Yunus MB, Dailey JW, Aldag DC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. J Rheumatol 1992;19:90-4.
22. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amino metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
23. Buskila D, Fefer P, Harman-Boehm I, et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in hyperprolactinemic women. J Rheumatol 1993;20:2112-5.
24. McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome. A comparison with rheumatoid arthritis. J Rheumatol 1989;16 Suppl 19:154-7.
25. Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 1992;35:1113-6.
26. Bennett RM. Muscle physiology and cold reactivity in the fibromyalgia syndrome. Rheum Dis Clin N Am 1989;15:135-47.
27. Qiao Z, Vaeroy H, Morkrid L. Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 1991;18:1383-9.
28. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-38.
29. Moldofsky H. Sleep and fibrositis syndrome. Rheum Dis Clin N Am 1989;15:91-103.
30. Russell IJ. Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci 1998;315:377-84.
31. Sorensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L. Hyperexcitability in fibromyalgia. J Rheumatol 1998;25:152-5.
32. Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM. Hypothalamic-pituitary-insulin-like growth factor-1 axis dysfunction in patients with fibromyalgia. J Rheumatol 1997;24:1384-9.
33. Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation in fibromyalgia patients and healthy subjects. Pain 1997;70:41-51.
34. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997;40:1928-39.
35. Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996;68:375-83.
36. Lorenz J, Grasedyck K, Bromm B. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996;100:165-8.
37. Sorensen J, Bengtsson A, Backman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine and ketamine. Scand J Rheumatol 1995;24:360-5.
38. Henriksson KG, Mense S. Pain and nociception in fibromyalgia: clinical and neurobiological considerations on etiology and pathogenesis. Pain Rev 1994;1:245-60.
39. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993;54:241-89.
40. Dubner R. Hyperalgesia and expanded receptive fields. Pain 1992;48:3-4.
41. Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation [editorial]. J Rheumatol 1992;19:846-50.
42. Hoheisel U, Mense S. Response behaviour of cat dorsal horn neurones receiving input from skeletal muscle and other deep somatic tissues. J Physiol (Lond) 1990;426:265-80.
43. Woolf CJ. Generation of acute pain: central mechanisms. Br Med Bull 1991;47:523-33.
44. Forseth KO, Gran JT, Husby G. A population study of the incidence of fibromyalgia syndrome among females aged 26-55 years [abstract]. Arthritis Rheum 1997;Suppl 40:S44.